These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22915585)

  • 1. Soluble prion protein inhibits amyloid-β (Aβ) fibrillization and toxicity.
    Nieznanski K; Choi JK; Chen S; Surewicz K; Surewicz WK
    J Biol Chem; 2012 Sep; 287(40):33104-8. PubMed ID: 22915585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo.
    Fluharty BR; Biasini E; Stravalaci M; Sclip A; Diomede L; Balducci C; La Vitola P; Messa M; Colombo L; Forloni G; Borsello T; Gobbi M; Harris DA
    J Biol Chem; 2013 Mar; 288(11):7857-7866. PubMed ID: 23362282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy.
    Nieznanska H; Bandyszewska M; Surewicz K; Zajkowski T; Surewicz WK; Nieznanski K
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2143-2153. PubMed ID: 29604335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.
    Rushworth JV; Griffiths HH; Watt NT; Hooper NM
    J Biol Chem; 2013 Mar; 288(13):8935-51. PubMed ID: 23386614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.
    Rösener NS; Gremer L; Reinartz E; König A; Brener O; Heise H; Hoyer W; Neudecker P; Willbold D
    J Biol Chem; 2018 Oct; 293(41):15748-15764. PubMed ID: 30131337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-prion RNA aptamer R12 disrupts the Alzheimer's disease-related complex between prion and amyloid β.
    Iida M; Mashima T; Yamaoki Y; So M; Nagata T; Katahira M
    FEBS J; 2019 Jun; 286(12):2355-2365. PubMed ID: 30916478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Prion Peptide 107-120 Protects Neuroblastoma SH-SY5Y Cells against Oligomers Associated with Alzheimer's Disease.
    Rezvani Boroujeni E; Hosseini SM; Fani G; Cecchi C; Chiti F
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The engineered peptide construct NCAM1-Aβ inhibits fibrillization of the human prion protein (PrP).
    Gielnik M; Zhukova L; Zhukov I; Gräslund A; Kozak M; Wärmländer S
    Acta Biochim Pol; 2022 Feb; 69(1):257-261. PubMed ID: 35143147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural details of amyloid β oligomers in complex with human prion protein as revealed by solid-state MAS NMR spectroscopy.
    König AS; Rösener NS; Gremer L; Tusche M; Flender D; Reinartz E; Hoyer W; Neudecker P; Willbold D; Heise H
    J Biol Chem; 2021; 296():100499. PubMed ID: 33667547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble Prion Protein Binds Isolated Low Molecular Weight Amyloid-β Oligomers Causing Cytotoxicity Inhibition.
    Williams TL; Choi JK; Surewicz K; Surewicz WK
    ACS Chem Neurosci; 2015 Dec; 6(12):1972-80. PubMed ID: 26466138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W; Du Y; Bai M; Xi Y; Li Z; Miao J
    J Pept Sci; 2013 Mar; 19(3):159-65. PubMed ID: 23349038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues.
    Chen S; Yadav SP; Surewicz WK
    J Biol Chem; 2010 Aug; 285(34):26377-83. PubMed ID: 20576610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cellular prion protein traps Alzheimer's Aβ in an oligomeric form and disassembles amyloid fibers.
    Younan ND; Sarell CJ; Davies P; Brown DR; Viles JH
    FASEB J; 2013 May; 27(5):1847-58. PubMed ID: 23335053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers.
    Laurén J; Gimbel DA; Nygaard HB; Gilbert JW; Strittmatter SM
    Nature; 2009 Feb; 457(7233):1128-32. PubMed ID: 19242475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular prion protein targets amyloid-β fibril ends via its C-terminal domain to prevent elongation.
    Bove-Fenderson E; Urano R; Straub JE; Harris DA
    J Biol Chem; 2017 Oct; 292(41):16858-16871. PubMed ID: 28842494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
    Wang L; Eom K; Kwon T
    Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.